Kenmotsu H, Yamamoto N, Misumi T, Yoh K, et al. Five-Year Overall Survival Analysis of the JIPANG Study: Pemetrexed or Vinorelbine Plus Cisplatin for Resected Stage II-IIIA Nonsquamous Non-Small-Cell Lung Cancer. J Clin Oncol 2023 Sep 1:JCO2300179. doi: 10.1200/JCO.23.00179.
PMID: 37656928